Divya Gupta, MD
Advanced Heart Failure and Transplant Cardiology · Atlanta, GANPI 1962606392
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,581 of the $8,076 with a category attached, or 69.1%. Every reported general payment came from a single manufacturer, Abbott. Reporting peaked in 2023 at $7,084 and has fallen 97.6% since, to $172 in 2024. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in GA, where the typical reported total is $8,076.
Across 18 payments — averaging $448.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
Across 12 payments — averaging $8010.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$86K
- E.r. Squibb & Sons, L.L.C.$9K
- Abbott$750
- Carmat$632
What the payments were for
- Consulting fees$5,58169%
- Travel & lodging$1,91424%
- Food & beverage$5817%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 18 | $8,076 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,076 in reported general payments places this provider in the 50th percentile of 40 advanced heart failure and transplant cardiology providers in Georgia.
See all advanced heart failure and transplant cardiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 120 | $157,450 |
| FarxigaDapagliflozin Propanediol | 111 | $107,790 |
| JardianceEmpagliflozin | 104 | $104,713 |
| EliquisApixaban | 72 | $86,505 |
| Sirolimus | 40 | $19,897 |
| Tacrolimus | 83 | $12,951 |
| Enoxaparin Sodium | 46 | $12,653 |
| Mycophenolate Mofetil | 72 | $11,808 |
| Mycophenolic AcidMycophenolate Sodium | 15 | $9,792 |
| Valganciclovir Hcl | 12 | $6,746 |
| Eplerenone | 38 | $4,960 |
| DapagliflozinDapagliflozin Propanediol | 11 | $4,221 |
| Warfarin Sodium | 298 | $3,642 |
| Spironolactone | 281 | $2,797 |
| Torsemide | 170 | $2,615 |
Paid to pharmacies, not to this prescriber.
Other advanced heart failure and transplant cardiology in Atlanta
- Robert ColeAtlanta$213K
- Rahul LounganiAtlanta$51K
- Arun KrishnamoorthyAtlanta$37K
- Benjamin DemossAtlanta$17K
- Mehrdad ToosiAtlanta$15K
- Brenda HottAtlanta$8K
- Kunal BhattAtlanta$6K
- Mahmoud AbdouAtlanta$4K
- Chad MaoAtlanta$3K
- Sonjoy LaskarAtlanta$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.